CIG Pannonia Life Insurance OJSC (FRA:0CKA) Research & Development: €0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0CKA CIG Pannonia Life Insurance OJSC FRA:0CKA
49 GF Score
Price €0.84
GF Value €0.94
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is CIG Pannonia Life Insurance OJSC Research & Development?

CIG Pannonia Life Insurance OJSC FRA:0CKA 49 Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:0CKA with a GF Score™ of 49/100 and a GF Value™ of €0.94 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CIG Pannonia Life Insurance OJSC's Research & Development for the three months ended in Mar. 2026 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.

CIG Pannonia Life Insurance OJSC  (FRA:0CKA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CIG Pannonia Life Insurance OJSC Research & Development Related Terms

CIG Pannonia Life Insurance OJSC Research & Development Historical Data

* Premium members only.

The historical data trend for CIG Pannonia Life Insurance OJSC's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CIG Pannonia Life Insurance OJSC Research & Development Chart

CIG Pannonia Life Insurance OJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CIG Pannonia Life Insurance OJSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:0CKA
49GF Score
CIG Pannonia Life Insurance OJSC FRA:0CKA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CIG Pannonia Life Insurance OJSC Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
CIG Pannonia Life Insurance OJSC (FRA:0CKA) has a Research & Development of €0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on CIG Pannonia Life Insurance OJSC and its competitors.
Is CIG Pannonia Life Insurance OJSC's Research & Development too high?
CIG Pannonia Life Insurance OJSC's current Research & Development is €0.00 Mil. Overall, CIG Pannonia Life Insurance OJSC has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CIG Pannonia Life Insurance OJSC's Research & Development compare to AFL and MET?
CIG Pannonia Life Insurance OJSC's Research & Development of €0.00 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CIG Pannonia Life Insurance OJSC and its competitors. CIG Pannonia Life Insurance OJSC's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CIG Pannonia Life Insurance OJSC stock overvalued right now?
Based on GuruFocus' analysis, CIG Pannonia Life Insurance OJSC (FRA:0CKA) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.94, compared to a current price of €0.84 — trading 10.6% below its estimated fair value. The current Research & Development is €0.00 Mil. CIG Pannonia Life Insurance OJSC's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CIG Pannonia Life Insurance OJSC (FRA:0CKA), the current Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CIG Pannonia Life Insurance OJSC (FRA:0CKA) Overvalued in 2026?

Based on GuruFocus' analysis, CIG Pannonia Life Insurance OJSC stock appears to be undervalued. The current stock price of €0.84 is trading 10.6% below its estimated GF Value™ of €0.94. GuruFocus considers CIG Pannonia Life Insurance OJSC to be Modestly Undervalued.

Key valuation signals for FRA:0CKA:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.94 vs. price of €0.84 (10.6% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the FRA:0CKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CIG Pannonia Life Insurance OJSC Business Description

Other Exchanges CIGPANNONIA:Hungary
Address 11 Konyves Kalman Korut, Building B, Nepliget Center Business Center, Budapest, HUN, 1097
CIG Pannonia Life Insurance OJSC is an insurance company. The company mainly sells various insurance products including unit-linked life insurance, term life insurance, endowment insurance, health insurance, casco, freight liability and suretyship insurance and also offers investment fund management and portfolio management. The company carries its activities in Hungary, Romania, Slovakia, and Italy. In addition, the company sells riders and non-life insurance products.
49GF Score

Get the complete analysis for FRA:0CKA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.84
Price
€0.94
GF Value